Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. — FDA 510(k) Submissions

Tandem Diabetes Care, Inc. has submitted 24 FDA 510(k) premarket notifications since 2011, of which 22 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Alternate Controller Enabled Insulin Infusion Pump, Pump, Infusion, Insulin, Interoperable Automated Glycemic Controller, Medical Device Data System, Interoperable Automated Glycemic Controller, Insulin Suspend . Use the specialty filter in the sidebar to narrow results.